Table 1.

Future potential use of immunomodulators – critical areas.

• Postsurgical recurrence in Crohn’s disease

• Early therapeutic approach

• Definition of high risk patients

• Correlation between persistence of mucosal lesions and

– High relapse rate

– High hospitalization rate

– High surgery rate

– High dysplasia and colorectal cancer risk